Stock Information

Find everything you need to know regarding Cullinan Therapeutics, Inc. stock (Nasdaq: CGEM). Obtain stock quotes, access historical share price information, calculate investments, and learn more about our covering analysts.

Stock Quote and Performance

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Minimum 15 minutes delayed. Source: LSEG

Historical Price Lookup

Stock Data for the Week of June 15, 2026
Date Requested Open Price Day High Day Low Closing Price Volume Split Adjustment Factor
June 15, 2026 $13.94 $14.50 $13.52 $13.61 1,790,104 1:1
June 16, 2026 $13.70 $13.81 $13.17 $13.55 1,062,328 1:1

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.

Minimum 15 minutes delayed. Source: LSEG

Investment Calculator

Initial Investment on Jan 07, 2022
Original Shares:
1,000.00
Original Value:
$14,690.00
Current Shares:
1,000.00
Current Value:
$14,870.00
Current Price:
$14.87
Split Adjustment:
1
1.23% Return

Return calculations do not include reinvested cash dividends.

Minimum 15 minutes delayed. Source: LSEG

Analyst Coverage

Research Analysts and Their Affiliated Firms Following the Company
Firm Analyst Email Phone Type Rating
BTIG
Julian Harrison
Citi
Samantha Semenkow, Ph.D.
Clear Street
Kaveri Pohlman, PhD
Guggenheim
Brad Canino
HC Wainwright
Robert Burns / Raghuram. Selvaraju, Ph.D
JonesResearch
Boris Peaker
Leerink Partners
Andrew Berens
Morgan Stanley
Sean Laaman, PhD
Stifel
Alex Thompson, PhD
TD Cowen
Marc Frahm, PhD
UBS
David Dai
Wedbush
Robert Driscoll, PhD
William Blair
Matt Phipps, PhD

Cullinan Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Cullinan Therapeutics, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cullinan Therapeutics, Inc. or its management. Cullinan Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.